Elsevier

Journal of Vascular Surgery

Volume 13, Issue 2, February 1991, Pages 189-199
Journal of Vascular Surgery

Original Articles from the International Society for Cardiovascular Surgery, North American Chapter
Prospective randomized multicenter comparison of in situ and reversed vein infrapopliteal bypasses,☆☆

Presented at the Thirty-eighth Scientific Meeting of the North American Chapter, International Society for Cardiovascular Surgery, Los Angeles, Calif., June 4-6, 1990.
https://doi.org/10.1016/0741-5214(91)90211-CGet rights and content

Abstract

We have performed a prospective, randomized, multicenter study to compare in situ and reversed vein grafts for long limb salvage bypasses from the proximal thigh to an infrapopliteal artery. Three hundred eighty-four patients required an infrapopliteal bypass for critical lower extremity ischemia. Of these, 259 were excluded because a short vein bypass was performed or because the vein was considered inadequate. The remaining 125 patients had a randomized vein bypass, 63 reversed, 62 in situ. The two groups were similar with regard to risk factors, indications, graft dimensions, and outflow. Secondary patency at 30 months was similar for both techniques: reversed 67% ± 9% (±SE); in situ 69% ± 8%. For veins ≤3.0 mm in minimum distended diameter 24-month patency rates were 61% ± 22% for 12 in situ veins and 37% ± 29% for 10 reversed veins (p > 0.05). Angiographic evaluation of failing grafts revealed lesions similar in type and frequency in both types of grafts. These included focal (in situ, n = 4; reversed, n = 7 and diffuse vein hyperplasis (in situ, n = 2; reversed, n = 1), and inflow and outflow stenoses (in situ, n = 4; reversed, n = 3). The incidence of wound complications and the mortality rate were similar for the two groups. These data show no significant difference in overall patency rates for the two types of vein grafts at 2½ years. Because of the poor preliminary patency of reversed vein grafts ≤3.0 mm in minimum distended diameter, we suggest the in situ method be used preferentially when such small veins are encountered. Thirty percent of patients requiring a long infrapopliteal bypass had no vein suitable for an in situ graft, although an ectopic vein bypass was feasible. Thus surgeons performing these operations should be adept at both procedures. (J VASC SURG 1991;13:189-99.)

Section snippets

Methods

All three centers had considerable interest and experience in the performance of infrainguinal bypass procedures by use of both reversed and in situ vein grafts.3, 17, 23 All six participating surgeons were adept in the performance of both techniques, and all agreed to the following standard protocol for the evaluation, randomization, operative care, and postoperative follow-up of their patients undergoing infrapopliteal bypass. Appropriate approval of this protocol was obtained from the

Excluded or withdrawn patients

Seventy-four (37%) of the 199 candidates for randomization (Table I) were excluded before randomization or withdrawn after randomization because the vein was unsuitable for use because it was absent, too small (<2.5 mm in MDD), fibrotic, or had an intraluminal obstruction to the passage of a soft catheter. Fiftynine patients (30%) underwent a bypass with a contralateral saphenous or another ectopic vein, and 15 (7%) received a prosthetic polytetrafluoroethylene graft.

Clinical characteristics of patients and vein grafts in the randomized group

Characteristics of the

Discussion

Infrainguinal reconstructive arterial surgery for limb salvage is now widely accepted and practiced.1, 2 Operability rates and limb salvage rates have increased dramatically.3 In addition, as techniques for performing infrainguinal bypasses in general and infrapopliteal bypasses in particular have improved, the patency rates have increased. Important contributions to these improved results have been the introduction of fine instruments, meticulous techniques, and recognition of the frequent

References (33)

  • KR Wengerter et al.

    Influence of vein size (diameter) on infrapopliteal reversed vein graft patency

    J Vasc Surg

    (1990)
  • ST Bartlett et al.

    The reoperative potential of infrainguinal bypass: long-term limb and patient survival

    J Vasc Surg

    (1987)
  • D Buchbinder et al.

    Comparison of patency rate and structural changes of in situ and reversed vein arterial bypass

    J Surg Res

    (1981)
  • WR Brody et al.

    Changes in vein grafts following aorto-coronary bypass induced by pressure and ischemia

    J Thorac Cardiovasc Surg

    (1972)
  • BS Maini et al.

    Effect of arterial reconstruction on limb salvage: a ten-year appraisal

    Arch Surg

    (1978)
  • FJ Veith et al.

    Progress in limb salvage by reconstructive arterial surgery combined with new or improved adjunctive procedures

    Ann Surg

    (1981)
  • Cited by (109)

    • Non-reversed and Reversed Great Saphenous Vein Graft Configurations Offer Comparable Early Outcomes in Patients Undergoing Infrainguinal Bypass

      2022, European Journal of Vascular and Endovascular Surgery
      Citation Excerpt :

      The reversed vein bypass uses mobilisation of the entire length of the GSV, which is subsequently reversed in configuration to allow the passage of flow through valves. Many studies have evaluated outcomes of in situ and reversed vein bypasses with mixed results regarding the superiority of either technique.8–15 First described by Batson and Sottiurai in 1985, the non-reversed, transposed vein bypass combines two important attributes of both reversed and in situ techniques.16

    • Systematic review and meta-analysis of saphenous vein harvesting and grafting for lower extremity arterial bypass

      2021, Journal of Vascular Surgery
      Citation Excerpt :

      These studies reported no significant differences in the patency of LEAB between continuous incision harvesting and skip incision harvesting (Peto OR, 0.93; 95% CI, 0.83-1.04; P = .20; I2 = 94%). A total of 20 studies reported data on reversed vs in situ bypass grafting (Table III).13,14,37,40-55 We did not find evidence of a difference between reversed and in situ grafting in the mortality rate (RR, 0.91; 95% CI, 0.45-1.87; P = .80; I2 = 0%) or wound complications (RR, 0.91; 95% CI, 0.45-1.82; P = .80; I2 = 65%).

    • Reconstructive Surgery for Peripheral Artery Disease

      2013, Vascular Medicine: A Companion to Braunwald's Heart Disease: Second Edition
    View all citing articles on Scopus

    Supported in part by the Manning Foundation, the Anna S. Brown Trust, the Hunter Surgical Research Fund, and the New York Institute for Vascular Studies.

    ☆☆

    Reprint requests: Frank J. Veith, MD, 111 E 210 St., New York, NY 10467.

    View full text